Janux Therapeutics, Inc.

JANXNasdaq· Pharmaceutical Preparations

Price History

Revenue

$10.0M

▼ 5.6% YoY

Net Income

-$113.6M

▼ 64.7% YoY

EPS

$-1.83

▼ 43.0% YoY

Cash

$52.3M

▼ 87.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.